Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Dividends Paid - CommonFree Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesSales of Property, Plant and EquipmentShare-based Compensation
Growth Metrics
Income Statement
Others
Ratios

National Healthcare Properties (NHPAP) Capital Expenditures (2016 - 2025)

Historic Capital Expenditures for National Healthcare Properties (NHPAP) over the last 13 years, with Q3 2025 value amounting to $4.6 million.

  • National Healthcare Properties' Capital Expenditures fell 1245.95% to $4.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was $22.5 million, marking a year-over-year increase of 3695.73%. This contributed to the annual value of $21.9 million for FY2024, which is 3786.9% down from last year.
  • As of Q3 2025, National Healthcare Properties' Capital Expenditures stood at $4.6 million, which was down 1245.95% from $6.7 million recorded in Q2 2025.
  • National Healthcare Properties' Capital Expenditures' 5-year high stood at $101.9 million during Q3 2021, with a 5-year trough of $3.3 million in Q1 2022.
  • For the 5-year period, National Healthcare Properties' Capital Expenditures averaged around $16.3 million, with its median value being $6.7 million (2021).
  • As far as peak fluctuations go, National Healthcare Properties' Capital Expenditures plummeted by 9264.27% in 2021, and later surged by 66843.85% in 2023.
  • Quarter analysis of 5 years shows National Healthcare Properties' Capital Expenditures stood at $13.2 million in 2021, then fell by 22.5% to $10.2 million in 2022, then fell by 3.69% to $9.8 million in 2023, then tumbled by 43.9% to $5.5 million in 2024, then fell by 16.7% to $4.6 million in 2025.
  • Its Capital Expenditures stands at $4.6 million for Q3 2025, versus $6.7 million for Q2 2025 and $5.7 million for Q1 2025.